BAJAJ BROKING

Notification
No new Notification messages
Hexaware Technologies IPO is Open!
Apply for the Hexaware Technologies IPO through UPI in just minutes.
Q3 FY'25 Results of Top Companies!
From Reliance Industries to TCS to HDFC Bank, check out the latest quarterly results with financial highlights, key performance metrics, and more!
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
medinova diagnostic services l stock

MEDINOVA DIAGNOSTIC SERVICES L Share Price

36.4 -0.01 (-0.02%)
14 Feb 2025 | 03:25 PM Healthcare NSE: MEDINOV

MEDINOVA DIAGNOSTIC SERVICES L Share Price Update

As of the latest trading session, MEDINOVA DIAGNOSTIC SERVICES L share price is currently at 36.4, which is down by -0.01 from its previous closing. Today, the stock has fluctuated between 34.70 and 37.00. Over the past year, MEDINOVA DIAGNOSTIC SERVICES L has achieved a return of 3.94 %. In the last month alone, the return has been -7.52 %. Read More...

MEDINOVA DIAGNOSTIC SERVICES L Performance

Day Range

Low34.70 High37.00
36.38

52 Week Range

Low 30.66 High 51.05
36.38

MEDINOVA DIAGNOSTIC SERVICES L Share Price

526301

MEDINOV

img img img img
No Data Available

Open Price

37.00

Prev. Close

36.42

Volume (Shares)

2265.00

Total traded value

.80

Upper Circuit

43.65

Lower Circuit

29.11

Note: The current prices & values are delayed, Login to your account for live updates.

MEDINOVA DIAGNOSTIC SERVICES L Fundamentals


(Standalone)

Market Cap (Cr) 36.33
PE Ratio (TTM) 39.98
Book Value / Share -1.63
Beta 0.40
ROE 6.76%
EPS (TTM) 0.91
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.20

MEDINOVA DIAGNOSTIC SERVICES L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 1.75
Operating Expense 1.56
Net Profit 0.20
Net Profit Margin (%) 11.42
Earnings Per Share (EPS) 0.20
EBITDA 0.41
Effective Tax Rate (%) 16.66
Particulars SEP 2024 (Values in Cr)
Revenue 1.98
Operating Expense 1.66
Net Profit 0.25
Net Profit Margin (%) 12.62
Earnings Per Share (EPS) 0.25
EBITDA 0.51
Effective Tax Rate (%) 29.41
Particulars JUN 2024 (Values in Cr)
Revenue 1.86
Operating Expense 1.65
Net Profit 0.17
Net Profit Margin (%) 9.13
Earnings Per Share (EPS) 0.17
EBITDA 0.37
Effective Tax Rate (%) 22.72
Particulars MAR 2024 (Values in Cr)
Revenue 1.92
Operating Expense 1.68
Net Profit 0.29
Net Profit Margin (%) 15.10
Earnings Per Share (EPS) 0.30
EBITDA 0.56
Effective Tax Rate (%) 25.64
Particulars DEC 2023 (Values in Cr)
Revenue 1.82
Operating Expense 1.70
Net Profit 0.12
Net Profit Margin (%) 6.59
Earnings Per Share (EPS) 0.12
EBITDA 0.33
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Revenue 7.78
Operating Expense 7.02
Net Profit 0.75
Net Profit Margin (%) 9.64
Earnings Per Share (EPS) 0.75
EBITDA 1.71
Effective Tax Rate (%) 25.49
Particulars MAR 2023 (Values in Cr)
Revenue 7.76
Operating Expense 7.13
Net Profit 0.63
Net Profit Margin (%) 8.11
Earnings Per Share (EPS) 0.63
EBITDA 1.69
Effective Tax Rate (%) 27.58
Particulars MAR 2022 (Values in Cr)
Revenue 11.51
Operating Expense 9.18
Net Profit 2.07
Net Profit Margin (%) 17.98
Earnings Per Share (EPS) 2.08
EBITDA 3.21
Effective Tax Rate (%) 18.82
Particulars MAR 2021 (Values in Cr)
Revenue 11.32
Operating Expense 9.32
Net Profit 2.17
Net Profit Margin (%) 19.16
Earnings Per Share (EPS) 2.17
EBITDA 2.92
Effective Tax Rate (%) 5.67
Particulars MAR 2020 (Values in Cr)
Revenue 5.49
Operating Expense 6.02
Net Profit -0.30
Net Profit Margin (%) -5.46
Earnings Per Share (EPS) -0.30
EBITDA 0.55
Effective Tax Rate (%) -11.11
Particulars MAR 2024 (Values in Cr)
Book Value / Share -3.14
ROE % 18.01
ROCE % 17.34
Total Debt to Total Equity 0.00
EBITDA Margin 29.79
Particulars MAR 2023 (Values in Cr)
Book Value / Share -5.16
ROE % 15.05
ROCE % 14.61
Total Debt to Total Equity 0.00
EBITDA Margin 28.83
Particulars MAR 2022 (Values in Cr)
Book Value / Share -6.84
ROE % 21.44
ROCE % 19.76
Total Debt to Total Equity 0.00
EBITDA Margin 29.55
Particulars MAR 2021 (Values in Cr)
Book Value / Share -7.23
ROE % 196.40
ROCE % 36.35
Total Debt to Total Equity 0.00
EBITDA Margin 24.65
Particulars MAR 2020 (Values in Cr)
Book Value / Share -9.21
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 17.05
Particulars MAR 2024 (Values in Cr)
Book Value / Share -2.07
ROE % 6.76
ROCE % 9.69
Total Debt to Total Equity 0.00
EBITDA Margin 22.49
Particulars MAR 2023 (Values in Cr)
Book Value / Share -2.84
ROE % 5.68
ROCE % 8.63
Total Debt to Total Equity 0.00
EBITDA Margin 22.16
Particulars MAR 2022 (Values in Cr)
Book Value / Share -3.48
ROE % 18.65
ROCE % 18.82
Total Debt to Total Equity 0.00
EBITDA Margin 28.32
Particulars MAR 2021 (Values in Cr)
Book Value / Share -5.58
ROE % 126.53
ROCE % 44.50
Total Debt to Total Equity 0.00
EBITDA Margin 25.80
Particulars MAR 2020 (Values in Cr)
Book Value / Share -7.71
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 10.20
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.91
Total Assets 5.38
Total Liabilities 5.38
Total Equity -3.12
Share Outstanding 9981640
Price to Book Ratio -14.82
Return on Assets (%) 37.15
Return on Capital (%) 106.59
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.77
Total Assets 4.47
Total Liabilities 4.47
Total Equity -5.13
Share Outstanding 9981640
Price to Book Ratio -6.18
Return on Assets (%) 37.17
Return on Capital (%) 271.07
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.31
Total Assets 4.44
Total Liabilities 4.44
Total Equity -6.80
Share Outstanding 9981640
Price to Book Ratio -9.08
Return on Assets (%) 51.08
Return on Capital (%) -534.7
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.71
Total Assets 4.37
Total Liabilities 4.37
Total Equity -7.50
Share Outstanding 9981640
Price to Book Ratio -4.10
Return on Assets (%) 46.24
Return on Capital (%) -66.66
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.21
Total Assets 4.05
Total Liabilities 4.05
Total Equity -9.36
Share Outstanding 9981640
Price to Book Ratio -1.84
Return on Assets (%) -6.36
Return on Capital (%) 6.41
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.61
Total Assets 6.01
Total Liabilities 6.01
Total Equity -2.06
Share Outstanding 9981640
Price to Book Ratio -14.82
Return on Assets (%) 12.52
Return on Capital (%) 25.65
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.61
Total Assets 6.33
Total Liabilities 6.33
Total Equity -2.83
Share Outstanding 9981640
Price to Book Ratio -6.18
Return on Assets (%) 9.94
Return on Capital (%) 21.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.30
Total Assets 6.68
Total Liabilities 6.68
Total Equity -3.46
Share Outstanding 9981640
Price to Book Ratio -9.08
Return on Assets (%) 31.02
Return on Capital (%) 90.91
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.70
Total Assets 4.63
Total Liabilities 4.63
Total Equity -5.55
Share Outstanding 9981640
Price to Book Ratio -4.10
Return on Assets (%) 46.74
Return on Capital (%) -94.83
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.21
Total Assets 4.02
Total Liabilities 4.02
Total Equity -7.67
Share Outstanding 9981640
Price to Book Ratio -1.84
Return on Assets (%) -7.35
Return on Capital (%) 8.1
Particulars MAR 2024 (Values in Cr)
Net Income 2.27
Cash from Operations 2.76
Cash from Investing -0.20
Cash from Financing -1.32
Net change in Cash 1.13
Free Cash Flow 2.98
Particulars MAR 2023 (Values in Cr)
Net Income 1.90
Cash from Operations 1.49
Cash from Investing -0.33
Cash from Financing -0.85
Net change in Cash 0.22
Free Cash Flow 1.88
Particulars MAR 2022 (Values in Cr)
Net Income 2.79
Cash from Operations 1.85
Cash from Investing -1.83
Cash from Financing 0.31
Net change in Cash -0.17
Free Cash Flow 2.02
Particulars MAR 2021 (Values in Cr)
Net Income 1.91
Cash from Operations 1.66
Cash from Investing -0.06
Cash from Financing -1.37
Net change in Cash 0.24
Free Cash Flow 1.84
Particulars MAR 2020 (Values in Cr)
Net Income -0.27
Cash from Operations 1.27
Cash from Investing -0.15
Cash from Financing -1.07
Net change in Cash 0.00
Free Cash Flow 1.29
Particulars MAR 2024 (Values in Cr)
Net Income 1.01
Cash from Operations 1.60
Cash from Investing -0.18
Cash from Financing -1.32
Net change in Cash 0.00
Free Cash Flow 1.79
Particulars MAR 2023 (Values in Cr)
Net Income 0.87
Cash from Operations 1.25
Cash from Investing -0.33
Cash from Financing -0.78
Net change in Cash 0.06
Free Cash Flow 1.64
Particulars MAR 2022 (Values in Cr)
Net Income 2.55
Cash from Operations 1.63
Cash from Investing -1.83
Cash from Financing 0.94
Net change in Cash 0.23
Free Cash Flow 1.80
Particulars MAR 2021 (Values in Cr)
Net Income 2.29
Cash from Operations 1.47
Cash from Investing -0.11
Cash from Financing -1.15
Net change in Cash 0.24
Free Cash Flow 1.66
Particulars MAR 2020 (Values in Cr)
Net Income -0.26
Cash from Operations 0.49
Cash from Investing -0.14
Cash from Financing -0.26
Net change in Cash 0.01
Free Cash Flow 0.49
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6266.65 68.77 12.02 90104.81 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 57.02 139.07 3.58 106.87 44.00 / 107.94
SHREE PACETRONIX LTD. 77.73 16.19 2.08 27.98 74.00 / 268.50
TRANSGENE BIOTEK LTD. 4.40 0.00 3.07 33.34 3.91 / 11.34
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6266.65 74.98 11.00 90104.81 5690.80 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 33.15 0.00 -17.75 24.76 29.25 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5986.10 31.72 6.72 6548.79 3250.25 / 6400.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 37.00
  • 26 Days 37.70
  • 10 Days 37.30
  • 50 Days 38.10
  • 12 Days 37.30
  • 100 Days 38.40
  • 20 Days 37.50
  • 200 Days 37.70
37.23
PIVOT
First Resistance 38.09
Second Resistance 39.75
Third Resistance 40.61
First Support 35.57
Second Support 34.71
Third Support 33.05
RSI 44.57
MACD -0.36
Commodity Channel Index (CCI) -98.13
ADX 43.12
Williams % R -60.93

Over 1 Month

down

-7.52

Over 3 Months

down

-10.19

Over 6 Months

down

2.19

Over 1 Year

down

3.94

Over 3 Years

down

-3.86

Over 5 Years

down

18.25

MEDINOVA DIAGNOSTIC SERVICES L Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

MEDINOVA DIAGNOSTIC SERVICES L Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
37.86
Promoter Holdings
62.13
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Vijaya Diagnostic Centre Limited Shareholding of Promoter and Promoter Group 6202220.0 62.14
Shankar Lal Saraf Public Shareholding 326500.0 3.27
Subba Lakshmi Champati Public Shareholding 297824.0 2.98
Kattamreddy Lakshminarayana Reddy Public Shareholding 125000.0 1.25
Padarthi Harinadha Reddy Public Shareholding 125000.0 1.25
Duvvuru Jalandhar Reddy Public Shareholding 100000.0 1.0
Muddu Krishna Reddy Oduru Public Shareholding 100000.0 1.0

MEDINOVA DIAGNOSTIC SERVICES L

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About MEDINOVA DIAGNOSTIC SERVICES L

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by MEDINOVA DIAGNOSTIC SERVICES L

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Medinova Diagnostic Services Ltd?

Answer Field

The share price of Medinova Diagnostic Services Ltd for NSE is ₹ 0.00 and for BSE is ₹ 36.38.

What is the Market Cap of Medinova Diagnostic Services Ltd?

Answer Field

The market cap of Medinova Diagnostic Services Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 36.30 Cr. as of now.

What is the 52 Week High and Low of Medinova Diagnostic Services Ltd?

Answer Field

The 52 Week High and Low of Medinova Diagnostic Services Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 51.05 and ₹ 30.66.

How to Buy Medinova Diagnostic Services Ltd share?

Answer Field

You can trade in Medinova Diagnostic Services Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Medinova Diagnostic Services Ltd?

Answer Field

The 1 year returns on the stock has been 3.94%.

What is the Current Share Price of Medinova Diagnostic Services Ltd?

Answer Field

Medinova Diagnostic Services Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 36.38 as on 14 Feb 2025 | 03:25 PM.

What is the Market Cap of Medinova Diagnostic Services Ltd Share?

Answer Field

The market cap of Medinova Diagnostic Services Ltd for NSE ₹ 0.0 & for BSE ₹ 36.30 as on 14 Feb 2025 | 03:25 PM.

What is the P/E Ratio of Medinova Diagnostic Services Ltd Share?

Answer Field

As on 14 Feb 2025 | 03:25 PM the price-to-earnings (PE) ratio for Medinova Diagnostic Services Ltd share is 39.98.

What is the PB ratio of Medinova Diagnostic Services Ltd Share?

Answer Field

As on 14 Feb 2025 | 03:25 PM, the price-to-book (PB) ratio for Medinova Diagnostic Services Ltd share is -1.63.

How to Buy Medinova Diagnostic Services Ltd Share?

Answer Field

You can trade in Medinova Diagnostic Services Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Medinova Diagnostic Services Ltd Share on Bajaj Broking App?

Answer Field

To buy Medinova Diagnostic Services Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Medinova Diagnostic Services Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9 Lacs+ Users

icon-with-text

4.1+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5100+ Cr MTF Book

icon-with-text
loader